Staging Disease Progression from Prodromal to Overt Stage of Alpha-synucleinopathies
Objective: To compute a disease progression model of the prodromal to overt synucleinopathy continuum, usable at single subject level. Background: Progression milestones to stage patients…Parkinson’s disease Symptoms Mitigated by Photobiomodulation: The Potential of the Tryptophan Kynurenine Ratio as a Marker for Responsiveness to Therapy.
Objective: To determine the potential of the tryptophan:kynurenine ratio (trp/kyn) as a marker for the responsiveness of Parkinson’s symptoms to treatment by photobiomodulation Background: The…Real world application of alpha-synuclein skin biopsy in the diagnosis of synucleinopathies at a tertiary care center
Objective: The goal of this study is to review the real-world application of alpha-synuclein skin biopsy at a tertiary care center. Background: Synucleniopathies including Parkinson’s…Digital measurement of ocular microtremor in Parkinson’s Disease: Analytical and clinical validation
Objective: This pilot study examined the analytical and clinical validation of OMT measurement via the iTremor ONE device in PwPD. Background: Ocular microtremor (OMT) is…Role of APOE Polymorphism and CSF Markers of AD Co-Pathology in the Cognitive Trajectories of Sporadic and Genetic Parkinson’s Disease: A Longitudinal Cohort Study
Objective: To evaluate if APOE genotype and CSF biomarkers of AD co-pathology are associated with distinct rates of cognitive decline in PD subtypes. Background: Cognitive…Cognitive Assessment in Parkinson’s Disease: A Mixed Methods Study of Current Neuropsychology Practices in Australia
Objective: To investigate the role of neuropsychologists, and their current practices for assessing cognition in Parkinson’s disease (PD). Background: Diagnosis and evaluation of cognitive disorders…Changes in Cognitive Function with Deep Brain Stimulation in PD patients with and without Freezing of Gait
Objective: To determine if deep brain stimulation (DBS) changes cognitive function in Parkinson’s Disease (PD), and if these cognitive changes may relate to gait dysfunction…Variations of Self-Perceived Cognitive Changes by Ethnicity in Parkinson’s Disease Patients
Objective: To study perceptions of cognitive function across ethnic groups by comparing a subjective rating with an objective assessment for patients with PD (PWP). Background:…A 6-Year Longitudinal Analysis from the Parkinson’s Progression Markers Initiative on Non-Motor Symptom Severity and Progression in GBA1-associated vs. sporadic Parkinson’s Disease
Objective: To compare GBA1-associated PD and sporadic PD progression based on NMS severity, using data from the Parkinson’s Progression Markers Initiative (PPMI) (https://www.ppmi-info.org) Background: Parkinson’s…Quality of Life Impact on Adults with Parkinson’s Disease Experiencing Morning Akinesia: Real-World Observational Findings
Objective: To compare the quality of life (QoL) in Parkinson’s Disease (PD) patients with and without morning akinesia (MA) in those using oral medications only…
- « Previous Page
- 1
- …
- 38
- 39
- 40
- 41
- 42
- …
- 436
- Next Page »